Evidence‐based approach for prevention of radiocontrast‐induced nephropathy
- 14 October 2009
- journal article
- review article
- Published by Wiley in Journal of Hospital Medicine
- Vol. 4 (8) , 500-506
Abstract
The frequency of radiocontrast administration is dramatically increasing, with over 80 million doses delivered annually worldwide. Although recently developed radiocontrast agents are relatively safe in most patients, contrast nephropathy (CN) is still a major source of in‐hospital and long‐term morbidity and mortality, particularly in patients with preexisting kidney disease. Multiple protocols for CN prevention have been studied; however, strict guidelines have not been established, in part because of conflicting efficacy data for most prevention approaches. In this work, we critically review the major trials that have addressed common CN prophylaxis strategies, including type of radiocontrast media, N‐acetylcysteine administration, extracellular fluid volume expansion, and hemofiltration/hemodialysis. We conclude with evidence‐based recommendations for CN prevention, which emphasize concurrent NaHCO3 infusion and N‐acetylcysteine administration. These guidelines should be helpful to hospitalists, who frequently order radiocontrast studies, and could therefore have a significant impact on prevention of CN. Journal of Hospital Medicine 2009;4:500–506. © 2009 Society of Hospital Medicine.Keywords
This publication has 57 references indexed in Scilit:
- Current role of sodium bicarbonate–based preprocedural hydration for the prevention of contrast-induced acute kidney injury: A meta-analysisAmerican Heart Journal, 2008
- Sodium Bicarbonate is Associated with an Increased Incidence of Contrast NephropathyClinical Journal of the American Society of Nephrology, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trialAmerican Heart Journal, 2007
- N-Acetylcysteine and contrast-induced nephropathy: A meta-analysis of 13 randomized trialsAmerican Heart Journal, 2006
- Estimation of Glomerular Filtration Rate in Diabetic SubjectsDiabetes Care, 2005
- Contrast-Induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variablesThe American Journal of Cardiology, 2005
- A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effectAmerican Heart Journal, 2004
- The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathyClinical Nephrology, 2004
- Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy**The opinions, interpretations, conclusions, and recommendations expressed in this article are those of the authors and are not necessarily endorsed by the U.S. Army.The American Journal of Cardiology, 2003